End-to-End Platform for Human Pluripotent Stem Cell Manufacturing

Industrialization of stem-cell based therapies requires innovative solutions to close the gap between research and commercialization. Scalable cell production platforms are needed to reliably deliver the cell quantities needed during the various stages of development and commercial supply. Human plu...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Puspa R., Tomney, Amarel, Woon, Marites T., Uth, Nicholas, Shafighi, Farjad, Ngabo, Igor, Vallabhaneni, Haritha, Levinson, Yonatan, Abraham, Eytan, Friedrich Ben-Nun, Inbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981419/
https://www.ncbi.nlm.nih.gov/pubmed/31877727
http://dx.doi.org/10.3390/ijms21010089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981419/
https://www.ncbi.nlm.nih.gov/pubmed/31877727
http://dx.doi.org/10.3390/ijms21010089

Ejemplares similares